Your search returned 2 results.

Results
	1.	Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. MedStar authors: Sugarbaker, Paul H PMID: 29260418 Year: 2018 Citation: Annals of Surgical Oncology. 25(3):667-673, 2018 Mar. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Baratti D, Chouliaras K, De Simone M, Deraco M, Elias D, Glehen O, Heyd B, Kusamura S, Levine EA, Morris D, RENAPE Working Group, Robella M, Russell G, Shen P, Sugarbaker P, Votanopoulos KI DOI: https://dx.doi.org/10.1245/s10434-017-6293-5 Add to cart (remove)
	2.	Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. MedStar authors: Bijelic, Lana Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 25120250 Year: 2015 Citation: Annals of Surgical Oncology. 22(5):1680-5, 2015 May. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bijelic L, Ihemelandu C, Sugarbaker PH DOI: http://dx.doi.org/10.1245/s10434-014-3977-y Add to cart (remove)

Refine your search